NOTA Laboratories is a cutting-edge brand that focuses on developing innovative healthcare solutions using Nitric Oxide (NO). With a mission to harness the therapeutic properties of NO, they aim to create antimicrobial, antiviral, anti-inflammatory, and anti-thrombotic applications in targeted areas of medicine. Established in 2014, NOTA Laboratories has dedicated its efforts to advancing the treatment of various debilitating and potentially life-threatening conditions and diseases.

This includes tackling Sars CoV-2 (COVID-19), the seasonal flu, the common cold, systemic inflammatory response syndrome (SIRS), chronic rhinosinusitis (CRS), COPD, and catheter-related bloodstream infections (CRBSI). Supported by generous funding from the US National Institutes of Health through the small business innovation program, NOTA Laboratories is at the forefront of research and development. Their team consists of respected academic researchers and specialized physicians, who are well-equipped to prove the safety and efficacy of their product pipeline.

Choose NOTA Laboratories for groundbreaking NO delivery platform technologies that aim to revolutionize healthcare